Advertisement
Screener

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Stock Issued

2.8 / 5 stars · 68/120 Roast Me

NEONC TECHNOLOGIES HOLDINGS, INC. Stock Issued

NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Stock Issued of $557.06 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:StockIssued1 · last filed 2026-08-10

  • NEONC TECHNOLOGIES HOLDINGS, INC. stock issued for the quarter ending 2025-12-31 was -$132.00.
  • NEONC TECHNOLOGIES HOLDINGS, INC. stock issued for the quarter ending 2025-09-30 was $132.00.
  • NEONC TECHNOLOGIES HOLDINGS, INC. stock issued for the quarter ending 2025-06-30 was $0.00.
  • NEONC TECHNOLOGIES HOLDINGS, INC. stock issued for the quarter ending 2025-03-31 was $557.06K.
  • NEONC TECHNOLOGIES HOLDINGS, INC. stock issued for fiscal 2025 was $557.06K.
Period endStock Issued 3 monthStock Issued 6 monthStock Issued 9 monthStock Issued 12 month
2025-12-31-$132.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$0.00
derived: sum of 2 quarters · filed 2026-03-31
$0.00
derived: sum of 3 quarters · filed 2026-08-10
$557.06K
10-K · filed 2026-03-31
2025-09-30$132.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
$132.00
derived: sum of 2 quarters · filed 2026-08-10
$557.19K
10-Q · filed 2025-11-14
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$557.06K
10-Q · filed 2026-08-10
2025-03-31$557.06K
10-Q · filed 2026-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Rallybio Corp (RLYB)United States$0.089B
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30